Literature DB >> 15184625

Confirming the validity and responsiveness of the Multiple Sclerosis Walking Scale-12 (MSWS-12).

C McGuigan1, M Hutchinson.   

Abstract

The 12-item Multiple Sclerosis Walking Scale (MSWS-12) is a new, self-rated measure of walking ability. The scale has not been independently validated for use in differing MS populations. One hundred forty-nine patients in the community and 53 hospital outpatients with MS completed the MSWS-12 and other outcome measures. The psychometric properties of the MSWS-12 were excellent, and in particular the scale is responsive to change.

Entities:  

Mesh：

Year:  2004        PMID： 15184625     DOI： 10.1212/01.wnl.0000127604.84575.0d

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  29 in total

1.  Psychometric performance of a generic walking scale (Walk-12G) in multiple sclerosis and Parkinson's disease.

Authors:  Stina Bladh; Maria H Nilsson; Gun-Marie Hariz; Albert Westergren; Jeremy Hobart; Peter Hagell
Journal:  J Neurol       Date:  2011-09-29       Impact factor: 4.849

2.  Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world.

Authors:  Myla D Goldman; Robert W Motl; John Scagnelli; John H Pula; Jacob J Sosnoff; Diego Cadavid
Journal:  Neurology       Date:  2013-10-30       Impact factor: 9.910

3.  Evaluating walking in patients with multiple sclerosis: which assessment tools are useful in clinical practice?

Authors:  Francois Bethoux; Susan Bennett
Journal:  Int J MS Care       Date:  2011

Review 4.  Spasticity Measurement.

Authors:  Belgin Petek Balci
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

5.  Feasibility and Impact of an 8-Week Integrative Yoga Program in People with Moderate Multiple Sclerosis-Related Disability: A Pilot Study.

Authors:  Evan T Cohen; David Kietrys; Susan Gould Fogerite; Mariella Silva; Kristen Logan; Donald A Barone; J Scott Parrott
Journal:  Int J MS Care       Date:  2017 Jan-Feb

6.  Clinimetric properties of a walking scale in peripheral neuropathy.

Authors:  R C Graham; R A C Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-30       Impact factor: 10.154

7.  Accelerometry and its association with objective markers of walking limitations in ambulatory adults with multiple sclerosis.

Authors:  Robert W Motl; Deirdre Dlugonski; Yoojin Suh; Madeline Weikert; Bo Fernhall; Myla Goldman
Journal:  Arch Phys Med Rehabil       Date:  2010-12       Impact factor: 3.966

8.  Talking the talk on walking the walk: a 12-item generic walking scale suitable for neurological conditions?

Authors:  A Holland; R J O'Connor; A J Thompson; E D Playford; J C Hobart
Journal:  J Neurol       Date:  2006-08-21       Impact factor: 4.849

9.  Treatment of walking impairment in multiple sclerosis with dalfampridine.

Authors:  Andrew R Blight
Journal:  Ther Adv Neurol Disord       Date:  2011-03       Impact factor: 6.570

10.  The e-MSWS-12: improving the multiple sclerosis walking scale using item response theory.

Authors:  Matthew M Engelhard; Karen M Schmidt; Casey E Engel; J Nicholas Brenton; Stephen D Patek; Myla D Goldman
Journal:  Qual Life Res       Date:  2016-06-24       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.